Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice
A Regional Expert Council meeting was held in Moscow on August 21, 2015 to consider different aspects of the efficiency and safety of using the first direct thrombin inhibitor dabigatran etexilate in real clinical practice. The complex and debatable issues of prevention of systemic thromboembolic ev...
Main Author: | A. V. Fonyakin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-01-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/568 |
Similar Items
-
Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke
by: A.V. Fonyakin
Published: (2014-06-01) -
The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation
by: A. V. Fonyakin
Published: (2015-06-01) -
The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality
by: B. A. Tatarsky, et al.
Published: (2020-05-01) -
Dabigatran etexilate: a direct thrombin inhibitor
by: M. Dugnani
Published: (2013-05-01) -
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows
by: Luca Masotti, et al.
Published: (2012-10-01)